Literature DB >> 16584062

The inborn errors of sialic acid metabolism and their laboratory investigation.

Karina P Gopaul1, Martin A Crook.   

Abstract

Sialic acid (SA), a terminal monosaccharide of glycoconjugates, has a central role in human biological function. Various point mutations result in the malmetabolism of SA and inherited disorders: Defective SA synthesis causes sialuria and defective SA catabolism causes sialidosis and sialic acid storage disease (SASD). These inborn errors of metabolism are characterised by increased urinary free SA. This article reviews biochemical and clinical features that are distinct to each disorder. In view of recent evidence indicating a wide underestimation in the prevalence of sialic acid disorders, laboratory methods for determining urinary free SA and its implications for screening and prenatal diagnosis are evaluated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16584062

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  4 in total

1.  Neuraminidase-1 is required for the normal assembly of elastic fibers.

Authors:  Barry Starcher; Alessandra d'Azzo; Patrick W Keller; Gottipati K Rao; Deepa Nadarajah; Alexsander Hinek
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-08       Impact factor: 5.464

2.  Diagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfalls.

Authors:  Barbara K Burton; Roberto Giugliani
Journal:  Eur J Pediatr       Date:  2012-03-01       Impact factor: 3.183

3.  Prenatal screening of sialic acid storage disease and confirmation in cultured fibroblasts by LC-MS/MS.

Authors:  Jeroen van den Bosch; Linda F Oemardien; Malgorzata I Srebniak; Monique Piraud; Jan G M Huijmans; Frans W Verheijen; George J G Ruijter
Journal:  J Inherit Metab Dis       Date:  2011-05-27       Impact factor: 4.982

Review 4.  Exploration of the Sialic Acid World.

Authors:  Roland Schauer; Johannis P Kamerling
Journal:  Adv Carbohydr Chem Biochem       Date:  2018-11-28       Impact factor: 12.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.